Eagle Capital Management, an investment management company, released its first quarter 2026 investor letter. A copy of the letter is available to download here. The letter notes that individual stocks and subsectors are now more reactive to sentiments, reducing market efficiency but creating opportunities to add value. Over the last decade, multi-asset managers, or pods, have grown significantly, operating with leverage, tight risk controls, and quickly cutting losers, often relying on earnings momentum. Growth managers have outperformed value managers, attracting flows; retail investors increasingly chase momentum, reducing overall diversity and amplifying momentum’s influence. It’s more valuable to find controversial or underexplored assets early and benefit as earnings grow. Eagle has capitalized on this trend, expecting continued opportunities. Investments should consider probabilities, building portfolios for various outcomes rather than betting on one, which allows for compound growth. The Strategy is generating strong long-term absolute returns. Please review the Strategy’s top five holdings to gain insights into their key selections for 2026.
In its first-quarter 2026 investor letter, Eagle Capital Management highlighted stocks like Humana Inc. (NYSE:HUM). Humana Inc. (NYSE:HUM) is an American insurance company that provides medical and specialty insurance products. On May 20, 2026, Humana Inc. (NYSE:HUM) closed at $304.10 per share. One-month return of Humana Inc. (NYSE:HUM) was 41.47%, and its shares gained 33.88% over the past 52 weeks. Humana Inc. (NYSE:HUM) has a market capitalization of $36.51 billion.
Eagle Capital Management stated the following regarding Humana Inc. (NYSE:HUM) in its Q1 2026 investor letter:
“UnitedHealth Group and Humana Inc. (NYSE:HUM), two of the leading providers of managed care, have significant scale advantages in a consolidated industry that outgrows the overall economy. The two companies have struggled over the past few years as Medicare Advantage went through a downcycle of cost/price squeeze. We believe conditions have bottomed and that we are transitioning to a multi-year improvement in margins and returns. Actions by each to reduce costs and implement AI through their businesses are incremental tailwinds. At our weighted position, we expect annual EPS growth exceeding 20%.”
Humana Inc. (NYSE:HUM) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 53 hedge fund portfolios held Humana Inc. (NYSE:HUM) at the end of the fourth quarter, compared to 60 in the previous quarter. While we acknowledge the risk and potential of Humana Inc. (NYSE:HUM) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Humana Inc. (NYSE:HUM) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Humana Inc. (NYSE:HUM) and shared the list of stocks Jim Cramer discussed. In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
